Tectonic Therapeutic, Inc.
General ticker "TECX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $411.2M (TTM average)
Tectonic Therapeutic, Inc. follows the US Stock Market performance with the rate: 11.5%.
Estimated limits based on current volatility of 5.3%: low 20.42$, high 22.68$
Factors to consider:
- Total employees count: 49 as of 2018
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [23.41$, 62.67$]
- 2025-12-31 to 2026-12-31 estimated range: [13.72$, 39.38$]
Financial Metrics affecting the TECX estimates:
- Negative: with PPE of -6.2 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -8.49 <= 0.06
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of -0.02 > -0.64
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: Industry earnings per price (median), % of -15.95 <= 0
Short-term TECX quotes
Long-term TECX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 |
|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM |
| Operating Expenses | $44.65MM | $58.02MM |
| Operating Income | $-44.65MM | $-58.02MM |
| Non-Operating Income | $1.82MM | $0.03MM |
| Interest Expense | $0.15MM | $0.11MM |
| R&D Expense | $36.97MM | $41.36MM |
| Income(Loss) | $-42.82MM | $-57.98MM |
| Profit(Loss)* | $-42.82MM | $-57.98MM |
| Stockholders Equity | $-84.64MM | $140.78MM |
| Assets | $39.40MM | $152.91MM |
| Operating Cash Flow | $-40.68MM | $-59.08MM |
| Capital expenditure | $0.28MM | $0.16MM |
| Investing Cash Flow | $-0.28MM | $-0.16MM |
| Financing Cash Flow | $33.75MM | $171.71MM |
| Earnings Per Share** | $-11.59 | $-3.93 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.